APA (7th ed.) Citation

Tang, Y., Chang, J. W., Huang, C., Fang, Y., Chang, C., Yang, C., . . . Wu, C. Epidermal Growth Factor Receptor Exon 19 Deletion Subtypes Do Not Influence Survival Outcomes Following First-line Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitors in Advanced Nonsmall Cell Lung Cancer Patients. Wolters Kluwer Medknow Publications.

Chicago Style (17th ed.) Citation

Tang, Yan-Jei, John Wen-Cheng Chang, Chen-Yang Huang, Yueh-Fu Fang, Ching-Fu Chang, Cheng-Ta Yang, Chih-Hsi Scott Kuo, Ping-Chih Hsu, and Chiao-En Wu. Epidermal Growth Factor Receptor Exon 19 Deletion Subtypes Do Not Influence Survival Outcomes Following First-line Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitors in Advanced Nonsmall Cell Lung Cancer Patients. Wolters Kluwer Medknow Publications.

MLA (9th ed.) Citation

Tang, Yan-Jei, et al. Epidermal Growth Factor Receptor Exon 19 Deletion Subtypes Do Not Influence Survival Outcomes Following First-line Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitors in Advanced Nonsmall Cell Lung Cancer Patients. Wolters Kluwer Medknow Publications.